0001894562-23-000026.txt : 20230616
0001894562-23-000026.hdr.sgml : 20230616
20230616174948
ACCESSION NUMBER: 0001894562-23-000026
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230614
FILED AS OF DATE: 20230616
DATE AS OF CHANGE: 20230616
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Foster-Cheek Kaye I
CENTRAL INDEX KEY: 0001312622
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41536
FILM NUMBER: 231022540
MAIL ADDRESS:
STREET 1: JOHNSON & JOHNSON
STREET 2: ONE JOHNSON & JOHNSON PLAZA
CITY: NEW BRUNSWICK
STATE: NJ
ZIP: 08933
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Prime Medicine, Inc.
CENTRAL INDEX KEY: 0001894562
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21 ERIE ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-465-0013
MAIL ADDRESS:
STREET 1: 21 ERIE ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
wf-form4_168695217738921.xml
FORM 4
X0407
4
2023-06-14
0
0001894562
Prime Medicine, Inc.
PRME
0001312622
Foster-Cheek Kaye I
C/O PRIME MEDICINE, INC.
21 ERIE STREET
CAMBRIDGE
MA
02139
1
0
0
0
0
Stock Option (right to buy)
14.83
2023-06-14
4
A
0
39062
0
A
2033-06-14
Common Stock
39062.0
39062
D
The shares subject to this option shall vest in full upon the earlier of (i) June 14, 2024 or (ii) the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date.
/s/ Gabriela Morales-Rivera, attorney-in-fact
2023-06-16